Role of quinones in the ascorbate reduction rates of S-nitrosoglutathione.
Quinones are one of the largest classes of antitumor agents approved for clinical use, and several antitumor quinones are in various stages of clinical and preclinical development. Many of these are metabolites of, or are, environmental toxins. Because of their chemical structure they are known to enhance electron transfer processes such as ascorbate oxidation and NO reduction. The paraquinones 2,6-dimethyl-1,4-benzoquinone (DMBQ), 1,4-benzoquinone, methyl-1,4-benzoquinone, 2,6-dimethoxy-1,4-benzoquinone, 2-hydroxymethyl-6-methoxy-1,4-benzoquinone, trimethyl-1,4-benzoquinone, tetramethyl-1,4-benzoquinone, and 2,3-dimethoxy-5-methyl-1,4-benzoquinone; the paranaphthoquinones 1,4-naphthoquinone, menadione, 1,4-naphthoquinone-2-sulfonate, 2-ethylsulfanyl-3-methyl-1,4-naphthoquinone and juglone; and phenanthraquinone (PHQ) all enhance the anaerobic rate of ascorbate reduction of GSNO to produce NO and GSH. Rates of this reaction were much larger for p-benzoquinones and PHQ than for p-naphthoquinone derivatives with similar one-electron redox potentials. The quinone DMBQ also enhances the rate of NO production from S-nitrosylated bovine serum albumin upon ascorbate reduction. Density functional theory calculations suggest that stronger interactions between p-benzo- or phenanthrasemiquinones and GSNO than between p-naphthosemiquinones and GSNO are the major causes of these differences. Thus, quinones, and especially p-quinones and PHQ, could act as enhancers of NO release from GSNO in biomedical systems in the presence of ascorbate. Because quinones are exogenous toxins that could enter the human body via a chemotherapeutic application or as an environmental contaminant, they could boost the release of NO from S-nitrosothiol storages in the body in the presence of ascorbate and thus enhance the responses elicited by a sudden increase in NO levels.
Sanchez-Cruz
Pedro
P
Department of Chemistry, University of Puerto Rico, Humacao, Puerto Rico 00791, USA.
Garcia
Carmelo
C
Alegria
Antonio E
AE
D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000031:analogs & derivatives / Q000737:chemistry*; D066298:In Vitro Techniques; D007700:Kinetics; D009569:Nitric Oxide / Q000096:biosynthesis / Q000737:chemistry; D010084:Oxidation-Reduction; D011809:Quinones / Q000737:chemistry* / Q000627:therapeutic use; D026422:S-Nitrosoglutathione / Q000737:chemistry*
D000970:Antineoplastic Agents; D011809:Quinones; D009569:Nitric Oxide; D026422:S-Nitrosoglutathione; D001205:Ascorbic Acid